We are monitoring the impact of COVID-19 on APAC NGS Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 95
Share on
Share on

Asia Pacific Next Generation Sequencing Market Research Report - By Product, Technology, Application and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 95
Pages: 145

APAC Next-Generation Sequencing Market Size (2021 to 2026)

The size of the Asia Pacific NGS Market is predicted to be worth USD 1.00 billion by the end of 2021 and is forecasted to grow USD 3.10 billion by 2026, showcasing a CAGR of 25.35% from 2021 to 2026. Thus, the Asia-Pacific market is expected to grow at a considerable rate throughout the forecast period. The expected growth can be attributed to Asian companies and government agencies working to boost their genomics industry and revenue generation in this area.

The Asia-Pacific region showcases healthy growth due to the innovation and increased funding provided by governments and private organizations. In addition, increased investment by biotechnology and pharmaceutical companies is also expected to increase market demand. This is due to increased investment in R & D activities due to the spread of cancer and infectious diseases. Also, the development of NGS bioinformatics solutions and the presence of key players in the region will further accelerate market growth.

Asia presents significant opportunities for investors/venture capitalists as the developed markets are saturated. The presence of noteworthy developments by China and Japan to integrate new technologies and the development of healthcare is majorly driving the Asia Pacific Market. In addition, R&D and clinical development frameworks of countries such as India and Australia have composed the Asia Pacific market to witness lucrative growth throughout the forecast period. The rise in the growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, growth in the Asia-Pacific population, increasing incidence of infectious diseases are few factors driving the market growth.

In addition, the anticipated decrease in the prices of genome sequencing due to the development of rapid, high-capacity whole genome sequencers by key players is expected to have an optimistic effect on market penetration rates over a few years. However, the storage and management of enormous data generated by sequencing and its interpretation, high reliability on grants & funding from the government, and fall in capital expenditure from academic institutions are challenges for the Asia-Pacific next-generation sequencing market.

This research report on the APAC NGS Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Software
  • Services

By Technology: 

  • Targeted Re-Sequencing
  • Whole Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

By Application: 

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture
  • Animals Research

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the APAC NGS market is the fastest-growing regional market in the global market. Asian companies adopt various marketing strategies to expand their marketing operations in other regional markets as the domestic market expands. For example, BGI acquired Complete Genomics, an Asia company that provides a next-generation sequencing platform for DNA for human genome analysis. Similarly, China partnered with the UK in December 2017 to expand the country's space for science and innovation.

The China NGS market dominated the APAC market in 2020 and is forecasted to account for the most significant share in the APAC region during the forecast period. China witnessed technological advancements in molecular biology; it has enhanced the sequencing procedures, which is expected to expand the market growth. As a result, the market players are implementing various strategies to gain a competitive advantage over the marketplace. Similarly, China has partnered with the UK to expand the country's space for science and innovation.

On the other hand, the Japanese NGS market is anticipated to register a promising share in the Asia-Pacific Next-generation sequencing market due to the increasing R&D activities of biopharmaceutical and pharmaceutical companies. In addition, major players in the market are introducing new products due to the growing healthcare expenditure.

Further, the Indian NGS market is one of the fastest-growing countries in the Asia Pacific.  Also, Favourable government policies, improving the healthcare sector, and increasing genome mapping programs contribute to the Next-generation sequencing market.

KEY MARKET PLAYERS:

Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc, Partek Inc., Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., DNASTAR Inc., Knome Inc., and Qiagen N.V. are some of the noteworthy companies operating in the APAC NGS market.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology          

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 China            

                6.3 India              

                6.4 Japan            

                6.5 South Korea

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Illumina, Inc.       

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences  

                8.5 Macrogen Inc.     

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.      

                8.12 CLC Bio (Qiagen)    

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific NGS Market By Region, From 2021 to 2026 (USD Billion)
  2. Asia-Pacific NGS Market By Product, From 2021 to 2026 (USD Billion)
  3. Asia-Pacific Software Market By Region, From 2021 to 2026 (USD Billion)
  4. Asia-Pacific Services Market By Region, From 2021 to 2026 (USD Billion)
  5. Asia-Pacific NGS Market By Technology, From 2021 to 2026 (USD Billion)
  6. Asia-Pacific Whole Targeted Re-Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  7. Asia-Pacific Genome Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  8. Asia-Pacific De Novo Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  9. Asia-Pacific Exome Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  10. Asia-Pacific RNA-Seq Market By Region, From 2021 to 2026 (USD Billion)
  11. Asia-Pacific ChIP-Seq Market By Region, From 2021 to 2026 (USD Billion)
  12. Asia-Pacific Methyl-Seq Market By Region, From 2021 to 2026 (USD Billion)
  13. Asia-Pacific NGS Market By Application, From 2021 to 2026 (USD Billion)
  14. Asia-Pacific Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  15. Asia-Pacific Drug Discovery Market By Region, From 2021 to 2026 (USD Billion)
  16. Asia-Pacific Biomarker Discovery Market By Region, From 2021 to 2026 (USD Billion)
  17. Asia-Pacific Personalized Medicine Market By Region, From 2021 to 2026 (USD Billion)
  18. Asia-Pacific Agriculture and Animals Research Market By Region, From 2021 to 2026 (USD Billion)
  19. China NGS Market By Product, From 2021 to 2026 (USD Billion)
  20. China NGS Market By Technology, From 2021 to 2026 (USD Billion)
  21. China NGS Market By Application, From 2021 to 2026 (USD Billion)
  22. India NGS Market By Product, From 2021 to 2026 (USD Billion)
  23. India NGS Market By Technology, From 2021 to 2026 (USD Billion)
  24. India NGS Market By Application, From 2021 to 2026 (USD Billion)
  25. Japan NGS Market By Product, From 2021 to 2026 (USD Billion)
  26. Japan NGS Market By Technology, From 2021 to 2026 (USD Billion)
  27. Japan NGS Market By Application, From 2021 to 2026 (USD Billion)
  28. South Korea NGS Market By Product, From 2021 to 2026 (USD Billion)
  29. South Korea NGS Market By Technology, From 2021 to 2026 (USD Billion)
  30. South Korea NGS Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample